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In 1945, when the authors were stationed at the William Beaumont General 
Hospital in El Paso, Texas, the Office of the Surgeon General directed them to 
conduct a field trial of Ointment Fungicidal, Medical Department Supply 
Item ~ 1322050. At that time the ointment was being manufactured in large 
quantities for release to medical officers throughout the world and very little 
clinical data regarding its usefulness had been accumulated. The formula for 
Ointment Fungicidal is: 
Undecylenic acid........... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5.0 
Triethanolamine........................................................... 3.0 
Methocel. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2. 0 
Propylene glycol. ................. . ........................................ 23.0 
Zinc stearate ......................... . ..... . .............................. 13.0 
Carbowax 1500 ................. , .......................................... 55.0 
Based on the earliest investigations which tended to show the superiority of 
Desenex Ointment (1A, B and C) and anticipating the published reports of 
several investigators who were then engaged in, or who had just completed 
clinical studies of Desenex Ointment, Doctor Clarence Livingood, the then newly 
appointed Consultant in Dermatology of the Office of the Surgeon General 
suggested a comparison of Desenex Ointment1 with Ointment Fungicidal to 
determine whether the addition of zinc undecylenate would enhance the power 
of undecylenic acid as a fungicide. Several reports (1A, B and C and 2) of the 
fungicidal value of propionic acid and sodium propionate had been published 
previously. Sopronol Ointment2 was therefore chosen to be compared with the 
undecylenic acid ointment (Ointment Fungicidal) and the undecylenic acid-zinc 
undecylenate ointment (Desenex Ointment). 
The trial was conducted from May, 1945, until November, 1945. During 
this period the mean temperature was 76.6°. The subjects were military per-
sonnel from Fort Bliss, Texas, and patients of the William Beaumont General 
Hospital. A total of 556 soldiers and officers V\.ith fungous infections of the 
* This study was made while the authors were serving in the Medical Corps, Army of the 
United States. 
Received for publication December 30, 1947. 
t The formula for Desenex Ointment is zinc undecylenate 20%, undecylenic acid 5%, 
water miscible base q.s. 
t The formula for Sopronol Ointment is sodium propionate 16.4%, propionic acid 3.6%, 
N-Propyl alcohollO%, zinc stearate 5%, carbowax base. 
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skin participated. Three hundred and twenty-one were treated with Ointment 
Fungicidal, 117 with Desenex Ointment and 118 with Sopronol Ointment. 
The largest percentage of the patients presented tinea pedis but the trial was 
not limited to dermatophytosis of the feet as it. was desired to obtain information 
on the effects of the ointments on fungous infections in all skin areas. The 
patients were selected at random, but an effort was made to include approxi-
mately equal percentages of patients with involvement of the feet, groins and with 
generalized infections in the three groups which were to be treated with Ointment 
Fungicidal, Desenex Ointment and Sopronol Ointment. When the trial was 
initiated we anticipated that the subjects selected for the trial would be available 
CHART 1 
The number and percentage of mild, moderate and severe infections treated with each ointment 
lllii.D MODERATE SEVERE 
OINTMENT TOTAL 
No. % No. % No. % 
Fungicidal. ......... 43 13 244 76 35 11 321 
Desenex ............. 16 13.6 73 62.4 28 23.9 117 
Sopronol. ........... 11 9.3 89 75.4 18 15.3 118 
CHART 2 
Results of treatment with Ointment Fungicidal. 
NUl[BEll OF WEEKS 
I NUl[BEll OF PATIENTS 
TREATED 
lJND4PllOVED Dll'llOVED CLINICALLY CV:U:D 
OF TREATHENT 
--
No. % No. % No. % No. % 
--- --- --- --- --- --- ---
---
1 to 2 11 3.4 5 45.5 6 54.6 0 0 
2 to 4 118 36.7 35 29.6 66 55.9 17 14.5 
4 to 8 104 32.5 12 11.5 57 54.8 35 33.7 
8 or more 88 27.4 27 30.7 49 55.7 12 13.6 
Total. ........... 321 79 24.6 178 55.4 64 20 
for treatment and observation for several months. The sudden end of the war 
jnterfered with the complete prosecution of our plans and in respect to this time 
element the study is incomplete. The data that were obtained, however, illus-
trate the purpose for which the trial was instituted. 
Each patient was examined before treatment and once weekly during treat-
ment by one or both of the authors. Scrapings for microscopic direct examina-
tion in KOH were made at the time of each clinical examination and were 
examined by one observer, Lieutenant William Boniece, Sn.C., of the Laboratory 
Service. In 496 patients direct examination of scrapings in KOH were positive 
for fungi. One hundred forty-eight were confirmed by culture. The predom-
inating fungus was Trichophyton gypseum which accounted for 81 per cent of the 
positive cultures. During the trial 1800 examinations of scrapings were made, 
of which 1318 were positive, 392 were negative and 59 were unsatisfactory. 
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Patients with infection graded as mild to moderate were treated on an ambula-
tory basis and were instructed to anoint the involved areas thoroughly each night. 
Patients with infections graded as severe were hospitalized and medication was 
applied each day and night. Chart 1 shows the distribution of severity of 
CHART 3 
Results of treatment with Desene:c Ointment 
NUMBER Ol!'.PATIENTS UNIMPROVED IMPROVED CLINICALLY CUIED 
NUYB>:Jt OF WEEKS TREATED 
OF Tl<EATllENT 
No. % No. % No. % No. % 
---
---
--- ---
--- ---
--- ---
1 to 2 4 3.4 1 25 3 75 0 0 
2 to 4 38 32.5 5 13.1 27 71 6 15.9 
4 to 8 56 47.8 12 21.4 23 41.1 11 37.5 
8 or more 19 16.2 5 26.3 6 31.5 8 42.2 
Total.. .......... 117 I 23 19.6 59 50.4 35 30 
CHART 4 
Results of treatment with Sopronol Ointment 
NUMBER OP PATIENTS UNIMPROVED IMPROVED CLINICALLY CURED 
NOKBER 01" W!:EKS TREATED 
OP TREATMENT 
No. % No. % No. % No. % 
---
--- ---
---
---
--- ---
1 to 2 6 5.1 4 66.6 2 33.3 0 0 
2 to 4 30 25.4 12 44 14 46.6 4 13.3 
4 to 8 47 39.8 16 34 24 51 7 15 
8 or more 35 29.7 14 44 14 40 7 20 
Total. ........... 118 46 38.9 54 45.8 18 15.2 
CHART 5 
Comparison of results of treatment with ointment fungicidal, Desene:c ointment and sopronol 
ointment 
NUYBEJt UNIMPROVED IMPROVED CLINICALLY CUU:D 
OINTJIENT OF 
PATIENTS No. % No. % No. % 
Fungicidal. ......... 321 79 24.6 178 55.4 64 20 
Desenex ............. 117 23 19.6 59 50.4 35 30 
Sopronol. ............ 118 46 38.9 I 54 45.8 18 15.2 
infections; it is comparable for each group, with the exception of a higher per cent 
of severe infections in the group treated with Desenex Ointment. 
The results obtained in the three groups are recorded in Charts 2, 3, 4 and 
5. At the end of observation each patient was graded as unimproved, improved, 
or clinically cured. It is difficult to define a cure of a cutaneous fungous infec-
tion. In general, absence of signs of inflammation and repeated negative labora-
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tory findings should be the criteria for a "cure". Unfortunately it was not 
possible for us to obtain skin scrapings of all the patients on their last visit during 
the last part of the trial due to unavoidable personnel problems. It was neces-
sary to depend in some cases on visual inspection to determine the results of 
treatment. 
CHART 6 
The incidence of irritation produced by the ointments 
OINTKENT 
Fungicidal. .... . ...... . ................. . 
Desenex .................... . ........... . 
Sopronol. .............................. . 
NUJIBER OF 
PATIENTS TREATED 
321 
117 
118 
CHART 7 
IIU1.ITATED BY TUA'l'KENT 
No. 
1 
0 
2 
% 
0.3 
0 
1.7 
The incidence of pruritus and the effect of the three ointments on this symptom 
NUilBER. Pl<UltiTUS Pl<UltiTUS PRURITUS PRUJtiTUS 
OF PRESENT ABSENT CONTROLLED UNCONTROLLED OINTKENT PATIENTS 
TREATED No. % No. % No. % No. % 
-- ---- -- -- -- -- --
F!J.ngicidal ..... . ......... 321 183 57 138 43 110 60.1 73 39.9 
Desenex .................. 117 62 53 55 47 45 72.6 17 27.4 
Sopronol. ...... .. ........ 118 68 57.6 50 42.3 31 45.6 37 54.4 
--------------
Total. ................. 556 313 56.3 243 43.7 I 
CHART 8 
'I'he incidence of hyperhidrosis and effect of fatty acid fungicidal ointments on hyperhidrons 
NUMBER HYPERHIDROSIS HYPERHYDROSIS HYPERHIDROSIS HYPERHIDROSIS 
OF PilE SENT ABSENT CONTROI.LED NOT CONTROLLED OINTHENT PATIENTS 
TREATED No. % No. % No. % No. % 
------ -- -- -- -- --
Fungicidal ............... 321 69 21.5 252 78.5 32 46.7 37 53.3 
Desenex ......... . ........ 117 23 19.7 94 80.3 13 56.5 10 43.5 
Sopronol. ................ 118 26 22.1 92 77.9 9 34.6 17 65.4 
--------
-,-1-Total. ................. 556 118 21.2 438 78.8 
Many investigators have pointed out the low incidence of irritation produced 
by the fatty acid fungicides (1, 2, 3, 4, 5, 6). Chart 6 shows the number of 
patients who were intolerant to the ointments tested during the trial. 
The influence of the ointments on the relief of pruritus was studied. It was 
interesting to discover that pruritus occurred in only 56.3% of all the patients 
with fungous infections prior to treatment. From the data in Chart 7 it appears 
that Ointment Fungicidal was more effective than Sopronol Ointment in con-
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trolling pruritus. However, Ointment Fungicidal exerted less antipruritic 
effect than Desenex Ointment. 
The association of hyperhidrosis and dermatophytosis of the feet is well known. 
An attempt was made to evaluate the effect of the three fatty acid fungicidal 
ointments on hyperhidrosis and the possible effect of hyperhidrosis on the course 
of the infection. From the data in Chart 8 Ointment Fungicidal was more 
effective than Sopronol Ointment and less effective than Desenex Ointment in 
controlling hyperhidrosis. 
DISCUSSION 
Experiences in the field trial of Ointment Fungicidal confirmed the observa-
tions of other investigators who have emphasized the non-irritating properties 
of the fatty acid fungicides. There are obvious advantages of a fungicidal oint-
ment which lacks irritating and potential sensitizing powers. This medical 
department supply item was issued to medical officers who, more often than not, 
had little experience in, or knowledge of, the diagnosis and treatment of fungous 
infections of the skin. Reports on military dermatology during the first part of 
the war reiterated the high incidence of superimpesed dermatitis in patients 
injudiciously treated with irritating fungicides. This often posed a more trouble-
some problem than the original infection. Ointment Fungicidal was released 
in useful quantities toward the latter part of the war. During the short period 
it was available it probably prevented many cases of "over treatment" dermatitis. 
The percentage of "cures" in this trial were not as impressive as the results 
of other investigators (1, 3, 4, 5, 6). Desenex Ointment proved to be the most 
effective of the three agents tested, yet it produced only 30 per cent clinical cures. 
Muskablit (4) reported that Desenex Ointment, used in conjunction with 
Desenex Powder in 32 patients with dermatomycosis of varied localizations, 
resulted in 68.7% cures in an average time of 35 days. Shapiro and Rothman (5) 
treated 98 patients with dermatomycosis in various locations with Desenex 
Ointment and observed clinical cure in 71.4%, improvement in 10.2%, and failure 
in 18.3%. In 63 of the patients treated by Shapiro and Rothman the feet were 
involved; complete cure was accomplished in 57 or 90.4% of this group within 
four weeks. Keeney et al. reported as "clear" 39% of 40 patients with tinea 
pedis after five weeks treatment with undecylenate-undecylenic acid ointment. 
Our results with Sopronol Ointment, the least effective of the three ointments 
studied, were disappointing (15.2% cures and 45.8% improvement). Keeney 
et al. reported 71% of 39 patients "clear except for scaling" after six weeks of 
treatment with propionate-propionic acid (1). Shaw (6) reported a comparative 
study of the effects of fatty acid ointments in the treatment of moderate and 
severe fungous infections of the feet. He was able to achieve a cure in 89.5% 
of 143 patients treated with undecylenic acid-undecylenate ointment for 2.9 
weeks; when propionic acid propionate ointment was employed cure was obtained 
in 62.6% of 174 patients in 3.7 weeks. Hopkins and his associates (3) made 
extensive field trials of various fungicides in 7500 voluntary patients at Fort 
Benning, Ga. They concluded that undecylenic acid and di-nitro-cyclohexyl-
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phenol gave the highest percentage of clinical results. They found a low inci-
dence of irritation due to undecylenic acid and stated that, "the high percentage 
of effectiveness and low incidence of irritation indicated that undecylenic acid 
was the best fungicide tested for routine treatment in subacute cases." Sulz-
berger and Kanof (7) summarized prophylaxis experiments on large groups of 
United States Navy personnel and found that undecylenic acid-undecylenate 
powder was the most effective agent of nine powders tested. 
There will always be difficulty over interpretation of clinical cures of fungous 
infections and differences of opinion regarding the value of fungicides will vary 
with the enthusiasm of the investigator and his criteria for a cure. The disparity 
of some of our results and those of the aforementioned investigators may not be 
too great when Chart 5 is critically analyzed. Lack of improvement occurred in 
only 19.6% of the group treated with Desenex Ointment, the most effective of the 
three ointments. In the case of Sopronol Ointment, the least effective, 38.9% 
were unimproved. Ointment Fungicidal, of intermediate effectiveness, failed 
to improve 24.6%. Many of the patients whom we have listed as improved were 
considerably benefited and perhaps might have been regarded as clinically cured 
by other observers. For example, Keeney et al. (1), in their comparative study 
of undecylenic-undecylenate acid ointment and propionate-propionic acid 
ointment, listed results under two categories, namely "clear" and "clear except 
for scaling". After six weeks treatment with the propionate-propionic acid 
ointment 42% were "dear", but when the clinical manifestation of scaling was 
removed from the tabulation 71% could be listed as "clear except for scaling". 
Keeney et al. state the opinion "Because scaling is not always a manifestation of 
fungous infection its omission from the compilation of data is permissible". 
Their comparison of the two ointments was based on this qualification. We have 
listed as clinically cured only those patients with completely normal skin. 
Hopkins et al. (3) also comment on the difficulty of determining a sharp end point 
to be regarded as a clinical cure. They found that very few of their infantry 
patients were free of any visible desquamation or some erythema on the sides of 
the toes. It is possible that the impressive results obtained with undecylenate-
undecylenic acid by Muskablit, Shapiro and Rothman and Shaw may have been 
ba.Sed on criteria, less rigid than ours, for a cure. The comparison of the three 
ointments in the trial can be considered valid however, as the observations were 
made by the authors according to identical standards for lack of improvement, 
improvement and clinical cure. Thus it can be concluded that in this clinical 
(field) trial Ointment Fungicidal was less effective in its fungicidal activity than 
Desenex Ointment but was superior to Sopronol Ointment. That the incidence 
of severe infections was greatest in the group treated with Desenex Ointment 
further warrants the above statement. Desenex Ointment caused no irritation 
in the 117 patients who were treated with it, whereas there were 0.3% reactions 
to Ointment Fungicidal and 1. 7% reactions to Sopronol Ointment. For the relief 
of pruritus Ointment Fungicidal was superior to Sopronol Ointment but less 
effective than Desenex Ointment. The same order of effectiveness prevailed in 
the control of complicating hyperhidrosis. 
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SUMMARY AND CONCLUSIONS 
1. A field trial of United States Ari'ay Ointment Fungicidal (active ingredient, 
5% undecylenic acid) was conducted to determine its clinical effectiveness. 
Desenex Ointment (active ingredients 5% undecylenic acid and 20% zinc unde-
cylenate) and Sopronol Ointment (active ingredients, sodium propionate 16.4% 
and propionic acid 3.6%) were utilized for comparison. Three hundred twenty-
one patients with fungus infections of the skin were treated with Ointment 
Fungicidal; one hundred seventeen with De sen ex Ointment; one hundred eighteen 
with Sopronol Ointment. 
2. Ointment Fungicidal proved to be less effective clinically as a fungicide 
than Desenex Ointment although it was more effective than Sopronol Ointment. 
The addition of zinc undecylenate apparently enhanced the fungicidal activity 
of undecylenic acid. 
3. Desenex, the most effective of the three ointments tested, accomplished 
clinical "cures" in 30% and improvement in 50.4% of one hundred and seventeen 
patients. These findings are in conformity with the results of previous workers. 
(La, b). Ointment Fungicidal "cured" 20% of three hundred twenty-one 
patients and improved 55.4%. Treatment with Sopronol Ointment resulted m 
15.2% "cures" and 45.8% improvement. 
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